Empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing.
Adjuvance is dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. We are commercializing synthetic methods of producing the world’s leading novel vaccine adjuvants.
SAPONEX is Adjuvance’s synthetic version of QS-21. Our lead compound, TiterQuil-1055, is a novel analog of QS-21 that is a superior adjuvant, with its significantly improved safety, efficacy and manufacturing characteristics.
We have a team of industry veterans that combines their diverse developmental and commercial experience within the pharmaceutical and healthcare industries. Our team possesses deep knowledge and a wide network of industry relationships.
